Mesothelioma Foundations

Mesothelioma Doctors

Over 30 Billion dollars in trust fund money has been set aside for asbestos victims.

Get a Free copy of Surviving Mesothelioma, Lean on Me, or 100 Questions & Answers About Mesothelioma

Mesolink.org now offeres Free Assistance with VA Claims and other benefits.

Georgia Cancer Specialist

Contact Information

1835 Savoy Drive Atlanta, GA 30341
(770) 496-9400

Georgia Cancer Specialists hosts a number of private care facilities throughout the state of Georgia. In fact, it is the largest private care facility in south east. Nearly forty oncologists serve 30 offices in the area. The majority of offices are located in metropolitan Atlanta. Other offices are scattered throughout the state near major city hubs.

Annually, 160,000 visits are conducted by physicians. Georgia Cancer Specialists is a leader in the community and is one of the first private facilities in Georgia to offer Phase I clinical trials. Phase I trials are cutting edge drugs generally reserved for healthy individuals to determine the safety of the drug administered.

Medical oncology, hematology, and radiation technology are treatments available for patients. In addition to the medical aspects of treatment, Georgia Cancer Specialists also offer services for after treatment care. The facility has a full-time nutritional expert, home health coordinator, licensed clinical social worker, and wellness counselor. Georgia Cancer Specialists is one of the few private facilities that offers these services to their patients and loved ones.

One of the main problems with current cancer treatments revolves around the fact that all cells are affected by chemotherapy drugs. Recent developments with targeted cancer therapy have reduced the affect of chemotherapy drugs on non-cancerous or benign cells. Targeted cancer therapy uses techniques that specifically “target” malignant cancer cells. Because of the novelty of targeted therapy, most private institutions do not have access to these drugs. However, Georgia Cancer Specialists are among the few private centers to receive cancer treatment drugs previously only available to academic centers.

Georgia Cancer Specialists has formed an alliance with the University of Alabama. The alliance has allowed the Georgia facility to receive leading edge cancer therapy treatments during Phase I and Phase II. The joint research between the academic research center and Georgia Cancer Specialists is expanding to five offices. The center primarily focuses on breast, lung, lymphoma, prostate and colon cancer. However, new anti-angiogenesis drugs under clinical trials may also treat rare cancer diseases caused by asbestos inhalation, such as epithelial mesothelioma. Anti-angiognesis drugs use gene replacement therapy in order to cut the blood supply to the tumor. This starves the tumor of oxygen and nutrients and thus, the tumor growth ceases.

Participation in clinical trials is not prevalent in the United States. Currently, only 2% of the nation’s population will join a clinical trial. However, eighteen percent of oncology patients at Georgia Cancer Specialists will participate due to increased life expectancies and availability of the trial drugs.

The center continues to apply for grants to conduct further research for cancer treatments. Recently, Georgia Cancer Specialists was awarded a grant from the United States Department of Defense for breast cancer research. The center continues to seek funds to accommodate patients suffering from all types of cancer.

The SILVA Study is currently conducted at a Georgia Cancer Specialists facility. The study is designed to monitor the behavior of a lung cancer vaccination. Of the centers participating in the study, Georgia Center Specialists was able to recruit the third largest group of patients in the nation. Additionally, the Study of Tamoxifen and Raloxifene (STAR) Trial is the largest clinical study in Georgia. Currently, 22,000 women have enrolled in the breast cancer prevention program in Atlanta, Georgia. Dr. Janice Galleshaw is the Principal Investigator and an oncologist conducting the clinical trial.

Georgia Cancer Specialists contribute to the research community by publishing manuscripts and abstracts to share its research developments. Ten publications have been submitted to the research community, including one manuscript and nine abstracts. As new research develops, scientists will continue its publications to provide awareness to the community.